JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
First of its kind screening for Glaucoma at grass root level over 10k screened already
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
hubergroup’s two newly added medical vans are dedicated to dental and eye care
The new facility will be able to handle four times as many patients as the previous facility.
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Subscribe To Our Newsletter & Stay Updated